{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:09:52Z","timestamp":1788617392322,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.anai.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:41:35Z","timestamp":1652139695000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oral immunotherapy for children with a high-threshold peanut allergy"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-6052","authenticated-orcid":false,"given":"Soad","family":"Haj Yahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diti","family":"Machnes-Maayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirly","family":"Frizinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramit","family":"Maoz-Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Offenganden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron S.","family":"Kenett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Hovav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona I.","family":"Kidon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anai.2022.05.001_bib0001","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/all.14666","article-title":"The global burden of illness of peanut allergy: a comprehensive literature review","volume":"76","author":"Lieberman","year":"2021","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2022.05.001_bib0002","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/all.14682","article-title":"The disease burden of peanut allergy in Denmark measured by disability-adjusted life years (DALYs)","volume":"76","author":"Jakobsen","year":"2021","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.05.001_bib0003","first-page":"516","article-title":"Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States","volume":"27","author":"Blaiss","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.anai.2022.05.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100512","article-title":"The Peanut Allergy Burden Study: impact on the quality of life of patients and caregivers","volume":"14","author":"Nowak-Wegrzyn","year":"2021","journal-title":"World Allergy Organ J"},{"issue":"5","key":"10.1016\/j.anai.2022.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jaip.2020.12.025","article-title":"A high proportion of Canadian allergists offer oral immunotherapy but barriers remain","volume":"9","author":"Mack","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.11.011","article-title":"Integrating oral immunotherapy into clinical practice","volume":"147","author":"Leonard","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaip.2020.07.009","article-title":"Five-year follow-up of early intervention peanut oral immunotherapy","volume":"9","author":"Herlihy","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2022.05.001_bib0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/JAA.S290915","article-title":"A practical, stepwise approach to peanut oral immunotherapy in clinical practice: benefits and risks","volume":"14","author":"Anagnostou","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"7","key":"10.1016\/j.anai.2022.05.001_bib0009","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.jaip.2020.03.043","article-title":"Peanut oral immunotherapy protects patients from accidental allergic reactions to peanut","volume":"8","author":"Trendelenburg","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.iac.2019.09.005","article-title":"Peanut oral immunotherapy: state of the art","volume":"40","author":"Tang","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2022.05.001_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.739224","article-title":"Diagnosis of peanut allergy in preschool children: the impact of skin testing with a novel composition of peanuts","volume":"9","author":"Kidon","year":"2021","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.anai.2022.05.001_bib0012","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1067\/mai.2002.129235","article-title":"The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy","volume":"110","author":"Wensing","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0013","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaci.2012.10.034","article-title":"Threshold dose distributions for 5 major allergenic foods in children","volume":"131","author":"Blom","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1710-1492-9-35","article-title":"Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol","volume":"9","author":"Zurzolo","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.05.001_bib0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2014.10.047","article-title":"How much is too much? Threshold dose distributions for 5 food allergens","volume":"135","author":"Ballmer-Weber","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"10.1016\/j.anai.2022.05.001_bib0016","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"PALISADE Group of Clinical Investigators","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2022.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2019.10.021","article-title":"Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: where do we go from here?","volume":"145","author":"Eiwegger","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.001_bib0018","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy - real life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"Suppl 24","key":"10.1016\/j.anai.2022.05.001_bib0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/pai.13171","article-title":"Oral desensitization in IgE-mediated food allergy: effectiveness and safety","volume":"31","author":"Calvani","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2021.05.021","article-title":"Managing food allergy when the patient is not highly allergic","volume":"10","author":"Sicherer","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2022.05.001_bib0021","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jaip.2017.03.027","article-title":"Home-based induction of sustained unresponsiveness in children with mild reactions to high doses of peanut","volume":"5","author":"Garvey","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0022","doi-asserted-by":"crossref","first-page":"e53465","DOI":"10.1371\/journal.pone.0053465","article-title":"Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible","volume":"8","author":"Glaumann","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.anai.2022.05.001_bib0023","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pai.12959","article-title":"Severity and threshold of peanut reactivity during hospital-based open oral food challenges: an international multicenter survey","volume":"29","author":"Arkwright","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.05.001_bib0024","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2019.06.038","article-title":"Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: a randomized controlled study","volume":"144","author":"Dua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.05.001_bib0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/all.12532","article-title":"Factors augmenting allergic reactions","volume":"69","author":"Niggemann","year":"2014","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.05.001_bib0026","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/all.12429","article-title":"EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2022.05.001_bib0027","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.jaci.2021.01.025","article-title":"Using data from food challenges to inform management of consumers with food allergy: a systematic review with individual participant data meta-analysis","volume":"147","author":"Patel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0028","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2014.09.001","article-title":"Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut","volume":"135","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaip.2020.09.043","article-title":"Two different composite markers predict severity and threshold dose in peanut allergy","volume":"9","author":"Cottel","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.05.001_bib0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2017.05.050","article-title":"Dose of allergens in a peanut snack (Bamba) associated with prevention of peanut allergy","volume":"141","author":"Hindley","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2016.10.010","article-title":"Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel","volume":"139","author":"Togias","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2022.05.001_bib0032","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2022.05.001_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2013.10.001","article-title":"Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions","volume":"2","author":"Wasserman","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10322","key":"10.1016\/j.anai.2022.05.001_bib0034","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622003969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622003969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:01Z","timestamp":1761053401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622003969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1081120622003969"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.05.001","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral immunotherapy for children with a high-threshold peanut allergy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}